August 11, 2020 1:21 pm ET Therapeutic Solution

August 11, 2020
1:21 pm ET
Therapeutic Solutions International Launches Campbell Neurosciences Division aimed at Biologically Identifying and Repairing Suicide-Prone Brains
PR Newswire
August 05, 2020
9:40 am ET
Therapeutic Solutions International Reports Reduction of Inflammation Associated Memory Impairment by QuadraMune(TM) Administration
PR Newswire
July 28, 2020
9:45 am ET
Therapeutic Solutions International Files Patent on Ability of QuadraMune Ingredient Pterostilbene to Reduce Inflammation while Stimulating Brain Protective Biological Pathways
PR Newswire
July 13, 2020
9:35 am ET
Therapeutic Solutions International Reports QuadraMune(TM) Inhibits Inflammation Induced Blood Clotting: Possible Implication for Ongoing Covid-19 Prevention Clinical Trial?
PR Newswire
9:35 am ET
Therapeutic Solutions International Reports QuadraMune(TM) Inhibits Inflammation Induced Blood Clotting: Possible Implication for Ongoing Covid-19 Prevention Clinical Trial?
PR Newswire
July 07, 2020
9:00 am ET
Therapeutic Solutions International Submits Publication on StemVacs(TM) Preclinical Data Supporting COVID-19 Indication
PR Newswire
June 30, 2020
10:35 am ET
Therapeutic Solutions International Universal Donor Immunotherapy StemVacs(TM) Activates Antiviral Immune Cells While Protecting Lungs From "Cytokine Storm"
PR Newswire
June 22, 2020
9:00 am ET
Therapeutic Solutions International Announces Intention to Use Clinical Stage NK Activating Cancer Immunotherapy for COVID-19
PR Newswire
June 15, 2020
8:53 am ET
Therapeutic Solutions International Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway Using QuadraMune(TM) in Animal Studies
PR Newswire